Impact of Obesity on Target Organ Damage in Patients with Metabolic Syndrome.
Svetlana KostićIvan TasićNikola StojanovićJelena RakocevicMarina Deljanin IlićDragan ĐorđevićViktor StoičkovIsidora TasićPublished in: Diagnostics (Basel, Switzerland) (2024)
MetSy and obesity significantly alter the levels of NO metabolites, iNOS, ox-LDL-Chol, and PAI-1. High prevalence of NAFLD in obese patients with MetSy requires active screening and treatment of potential risk factors.
Keyphrases
- metabolic syndrome
- insulin resistance
- weight loss
- risk factors
- uric acid
- type diabetes
- high fat diet induced
- adipose tissue
- cardiovascular risk factors
- weight gain
- oxidative stress
- bariatric surgery
- ms ms
- body mass index
- low density lipoprotein
- combination therapy
- physical activity
- nitric oxide
- nitric oxide synthase
- climate change
- human health
- obese patients